CMU researchers have published in Science a new 3D bioprinting method that brings the field of tissue engineering one step closer to being able to 3D print a full-sized, adult human heart.
A team of researchers from Carnegie Mellon University has published a paper in Science that details a new technique allowing anyone to 3D bioprint tissue scaffolds out of collagen, the major structural protein in the human body. This first-of-its-kind method brings the field of tissue engineering one step closer to being able to 3D print a full-sized, adult human heart.
The technique, known as Freeform Reversible Embedding of Suspended Hydrogels (FRESH), has allowed the researchers to overcome many challenges associated with existing 3D bioprinting methods, and to achieve unprecedented resolution and fidelity using soft and living materials.
Each of the organs in the human body, such as the heart, is built from specialized cells that are held together by a biological scaffold called the extracellular matrix (ECM). This network of ECM proteins provides the structure and biochemical signals that cells need to carry out their normal function. However, until now it has not been possible to rebuild this complex ECM architecture using traditional biofabrication methods.
What we’ve shown is that we can print pieces of the heart out of cells and collagen into parts that truly function, like a heart valve or a small beating ventricle.
Adam Feinberg, Professor, Biomedical Engineering and Materials Science & Engineering
“What we’ve shown is that we can print pieces of the heart out of cells and collagen into parts that truly function, like a heart valve or a small beating ventricle,” says Adam Feinberg, a professor of biomedical engineering (BME) and materials science & engineering, whose lab performed this work. “By using MRI data of a human heart, we were able to accurately reproduce patient-specific anatomical structure and 3D bioprint collagen and human heart cells.”
Over 4,000 patients in the United States are waiting for a heart transplant, while millions of others worldwide need hearts but are ineligible for the waitlist. The need for replacement organs is immense, and new approaches are needed to engineer artificial organs that are capable of repairing, supplementing, or replacing long-term organ function. Feinberg, who is a member of Carnegie Mellon’s Bioengineered Organs Initiative and the Next Manufacturing Center, is working to solve these challenges with a new generation of bioengineered organs that more closely replicate natural organ structures.
“Collagen is an extremely desirable biomaterial to 3D print with because it makes up literally every single tissue in your body,” explains Andrew Hudson, a BME Ph.D. student in Feinberg’s lab and co-first author on the paper. “What makes it so hard to 3D print, however, is that it starts out as a fluid—so if you try to print this in air it just forms a puddle on your build platform. So we’ve developed a technique that prevents it from deforming.”
The FRESH 3D bioprinting method developed in Feinberg’s lab allows collagen to be deposited layer-by-layer within a support bath of gel, giving the collagen a chance to solidify in place before it is removed from the support bath. With FRESH, the support gel can be easily melted away by heating the gel from room temperature to body temperature after the print is complete. This way, the researchers can remove the support gel without damaging the printed structure made of collagen or cells.
This method is truly exciting for the field of 3D bioprinting because it allows collagen scaffolds to be printed at the large scale of human organs. And it is not limited to collagen, as a wide range of other soft gels including fibrin, alginate, and hyaluronic acid can be 3D bioprinted using the FRESH technique, providing a robust and adaptable tissue engineering platform. Importantly, the researchers also developed open-source designs so that nearly anyone, from medical labs to high school science classes, can build and have access to low-cost, high-performance 3D bioprinters.
Looking forward, FRESH has applications in many aspects of regenerative medicine, from wound repair to organ bioengineering, but it is just one piece of a growing biofabrication field. “Really what we’re talking about is the convergence of technologies,” says Feinberg. “Not just what my lab does in bioprinting, but also from other labs and small companies in the areas of stem cell science, machine learning, and computer simulation, as well as new 3D bioprinting hardware and software.”
“It is important to understand that there are many years of research yet to be done,” adds Feinberg, “but there should still be excitement that we’re making real progress towards engineering functional human tissues and organs, and this paper is one step along that path.”
Learn more: 3D printing the human heart
The Latest on: 3D bioprinting
via Google News
The Latest on: 3D bioprinting
- Cryogenic 3D Printing Improves Bioprinting for Bone Regenerationon October 2, 2020 at 5:00 pm
Fried Vancraen is one of my favorite people in 3D printing. It was a pleasure working for him years ago, as well. I was therefore especially happy that Vancraen chose... Todd Grimm has been ...
- 3D Bioprinting Market Expected to Grow at CAGR 31.25% and Forecast to 2025on September 29, 2020 at 9:49 pm
D Bioprinting Market is valued at around USD 484.50 Million in 2017 and is evaluated to achieve USD 3250.60 Million ...
- Christchurch researcher 3D bioprinting body partson September 29, 2020 at 8:50 pm
A Christchurch researcher is developing technology he hopes can print human blood vessels and tissue. Biomedical engineer, Dr Khoon Lim, has been researching the technology for the past eight ...
- Preheating gelatin as a facile approach to increase 3D printing durationon September 29, 2020 at 7:21 am
Gelatin has often been hailed as a promising candidate for bioprinting and 3D food printing because it is generally inexpensive to produce, edible and non-toxic to cells. However, gelatin is ...
- Orgenesis Announces Agreement to Acquire Koligo Therapeutics, a Leader in Personalized Cell Therapieson September 29, 2020 at 3:46 am
Acquisition to support accelerated commercialization of Koligo’s KYSLECEL®, a personalized islet cell therapy available in the U.S. for chronic ...
- Orgenesis Announces Agreement to Acquire Koligo Therapeutics, a Leader in Personalized Cell ...on September 29, 2020 at 3:30 am
Acquisition to support accelerated commercialization of Koligo’s KYSLECEL®, a personalized islet cell therapy available in the U.S. for chronic and recurrent acute pancreatitis ...
- New Process can 3D Print Living Cells with Precision and Speedon September 28, 2020 at 5:00 pm
3D bioprinting has come a long way in recent years, with scientists using living tissue to print organs as complex as human skin. Researchers in Austria have unveiled an advancement with a process ...
- 3D printing is making a giant leap into health. That could change everythingon September 28, 2020 at 3:51 am
The process of bioprinting human tissue is a bit more involved than, say, 3D printing a new desk toy. First, you have to get some stem cells from the person who needs the new organ, culture them in ...
- Global 3D Bioprinting Market To Flourish At Double Digit CAGR During 2020–2026 - Zion Market Researchon September 25, 2020 at 5:33 am
Zion Market Research Reports added Latest Research Report titled “Global 3D Bioprinting Market To Flourish At Double Digit CAGR During 2020–2026 - Zion Market Research″ to its Large Report ...
via Bing News